Stocks › BMY
BRISTOL MYERS SQUIBB CO
BMY·NYSE·
United States·USD
United States·USD$59.59
+0.78 (+1.33%)
Close · Oct 6, 2026 · Close Prices from Tiingo.com
BMY
BRISTOL MYERS SQUIBB CO · NYSE
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
BMYS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of BMY by members of U.S. Congress · 305 on record · 15 in the last 12 months
Whale Activity
Position changes in BMY reported for 2026-09-30 by 6 tracked institutional filers
- Increased0
- New0
- Held0
- Decreased0
- Closed0
- No prior filing6
| Filer | Shares | Value | Change |
|---|---|---|---|
| Versant Capital Management, Inc | 73.6K | $4.6M | — |
| CACTI ASSET MANAGEMENT LLC | 35.5K | $2.2M | — |
| Ridgewood Investments LLC | 32.0K | $2.0M | — |
| Partnership Wealth Management, LLC | 29.9K | $1.9M | — |
| Miller Global Investments, LLC | 20.2K | $1.3M | — |
| PPS&V ASSET MANAGEMENT CONSULTANTS, INC. | 3,476 | $217K | — |
KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.
Insider Trading
Net shares bought (+) or sold (−) on the open market by BMY insiders, by quarter · Form 4
Recent Insider Transactions
3,744 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| Massacesi CristianEVP,Chief Med Offr,Head of Dev | Sale | −6,249 | $64.57 | $403K | Sep 9, 2026 | Form 4 ↗ |
| Holzer Phil MSVP and Controller | Sale | −500 | $67.50 | $34K | Aug 25, 2026 | Form 4 ↗ |
| Haller Julia ADirector | Option exercise | +20.5K | $53.76 | $1.1M | Jun 15, 2026 | Form 4 ↗ |
| Short Bartie WendyEVP, Corporate Affairs | Tax withholding | −3,876 | $54.72 | $212K | Jun 3, 2026 | Form 4 ↗ |
| Short Bartie WendyEVP, Corporate Affairs | Option exercise | +8,040 | $0.00 | $0 | Jun 3, 2026 | Form 4 ↗ |
| Lenkowsky AdamEVP, Chief Commercial Officer | Tax withholding | −599 | $58.22 | $35K | May 1, 2026 | Form 4 ↗ |
| Lenkowsky AdamEVP, Chief Commercial Officer | Other | −203 | $0.00 | $0 | May 1, 2026 | Form 4 ↗ |
| Lenkowsky AdamEVP, Chief Commercial Officer | Option exercise | +1,373 | $0.00 | $0 | May 1, 2026 | Form 4 ↗ |
| Shanahan KarinEVP, Chief Supply Chain & Ops | Tax withholding | −1,692 | $61.73 | $104K | Apr 1, 2026 | Form 4 ↗ |
| Shanahan KarinEVP, Chief Supply Chain & Ops | Option exercise | +3,307 | $0.00 | $0 | Apr 1, 2026 | Form 4 ↗ |
| Elkins David VEVP, Chief Financial Officer | Sale | −4,481 | $62.05 | $278K | Apr 1, 2026 | Form 4 ↗ |
| Elkins David VEVP, Chief Financial Officer | Sale | −25.5K | $61.60 | $1.6M | Apr 1, 2026 | Form 4 ↗ |
| Short Bartie WendyEVP, Corporate Affairs | Tax withholding | −828 | $60.13 | $50K | Mar 10, 2026 | Form 4 ↗ |
| Short Bartie WendyEVP, Corporate Affairs | Other | −2,207 | $0.00 | $0 | Mar 10, 2026 | Form 4 ↗ |
| Short Bartie WendyEVP, Corporate Affairs | Option exercise | +4,495 | $0.00 | $0 | Mar 10, 2026 | Form 4 ↗ |
| Short Bartie WendyEVP, Corporate Affairs | Tax withholding | −242 | $60.13 | $15K | Mar 10, 2026 | Form 4 ↗ |
| Short Bartie WendyEVP, Corporate Affairs | Other | −81 | $0.00 | $0 | Mar 10, 2026 | Form 4 ↗ |
| Short Bartie WendyEVP, Corporate Affairs | Option exercise | +749 | $0.00 | $0 | Mar 10, 2026 | Form 4 ↗ |
| Short Bartie WendyEVP, Corporate Affairs | Tax withholding | −205 | $60.13 | $12K | Mar 10, 2026 | Form 4 ↗ |
| Short Bartie WendyEVP, Corporate Affairs | Other | −72 | $0.00 | $0 | Mar 10, 2026 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding BMY · SEC Form N-PORT
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 64.8M | $3.74B | 0.16% | Jun 30, 2026 |
| VANGUARD 500 INDEX FUND VANGUARD INDEX FUNDS | 52.9M | $3.05B | 0.18% | Jun 30, 2026 |
| Schwab U.S. Dividend Equity ETF SCHWAB STRATEGIC TRUST | 48.6M | $2.78B | 2.93% | May 31, 2026 |
| iShares Core S&P 500 ETF iShares Trust | 28.1M | $1.62B | 0.18% | Jun 30, 2026 |
| Fidelity 500 Index Fund Fidelity Concord Street Trust | 26.1M | $1.49B | 0.18% | May 31, 2026 |
| State Street(R) SPDR(R) S&P 500(R) ETF Trust | 24.7M | $1.43B | 0.18% | Jun 30, 2026 |
| VANGUARD VALUE INDEX FUND VANGUARD INDEX FUNDS | 19.4M | $1.12B | 0.44% | Jun 30, 2026 |
| State Street(R) Health Care Select Sector SPDR(R) ETF SELECT SECTOR SPDR TRUST | 14.4M | $831.3M | 2.05% | Jun 30, 2026 |
| VANGUARD PRIMECAP FUND VANGUARD CHESTER FUNDS | 14.3M | $823.6M | 0.86% | Jun 30, 2026 |
| VANGUARD INSTITUTIONAL INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 11.1M | $638.8M | 0.18% | Jun 30, 2026 |
Mutual funds and ETFs whose N-PORT filings list BMY's shares (CUSIP 110122108), each fund at its latest report since Mar 7, 2026, largest positions first. Bonds, options and short positions are left out.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
- STATE STREET CORPORATIONSCHEDULE 13G · passive (13G) · 102.5M shares5.0%
Aug 7, 2026 · ↗ - Vanguard Capital ManagementSCHEDULE 13G · passive (13G) · 153.1M shares7.5%
Apr 29, 2026 · ↗ - The Vanguard GroupSCHEDULE 13G/A · passive (13G) · 0 shares0.0%
Mar 26, 2026 · ↗ - JPMORGAN CHASE & CO.SCHEDULE 13G · passive (13G) · 104.7M shares5.1%
Apr 25, 2025 · ↗ - BlackRock, Inc.SCHEDULE 13G/A · passive (13G) · 143.6M shares7.1%
Apr 17, 2025 · ↗
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming bristol myers squibb as client
- ADVANCED POLICY CONSULTING, LLCBRISTOL-MYERS SQUIBB COMPANY · 2026 Q3 · HCR—
Filing ↗ - FEDERAL STREET STRATEGIES, LLCBRISTOL MYERS SQUIBB COMPANY · 2026 Q2 · HCR$50K
Filing ↗ - TODD STRATEGY GROUPBRISTOL-MYERS SQUIBB COMPANY · 2026 Q2 · HCR, MMM$80K
Filing ↗ - BRISTOL-MYERS SQUIBB COMPANYBRISTOL-MYERS SQUIBB COMPANY · 2026 Q2 · TRD, HCR, MMM, TAX$3.2M
Filing ↗ - MILLER STRATEGIES, LLCBRISTOL-MYERS SQUIBB COMPANY · 2026 Q2 · HCR, MMM—
Filing ↗
Government Contracts
Federal awards to bristol myers squibb · USAspending
$5.6MAwarded · 26 contracts on record
- Department of Veterans AffairsCAMZYOS AND POMALYST$1.0M
Oct 1, 2026 · ↗ - Department of Veterans AffairsMAVACAMTEN (CAMZYOS) AND POMALIDOMIDE (POLMALYST)$371K
Jan 29, 2026 · ↗ - Department of Veterans AffairsCAMZYOS, POMALYST, AND REVLIMID$72K
Jan 20, 2026 · ↗ - Department of Veterans AffairsREVLIMID 10MG CAP$0
Jan 30, 2026 · ↗ - Department of Veterans AffairsEMERGENCY BREYANZI$0
Jun 30, 2026 · ↗ - Department of Veterans AffairsBREYANZI INJECTION MM8684$0
Aug 27, 2026 · ↗ - Department of Veterans AffairsBREYANZI INJECTION$364K
Sep 11, 2026 · ↗ - Department of Veterans AffairsABECMA INJECTION$379K
Aug 10, 2026 · ↗
U.S. Patents
Recent USPTO applications naming BRISTOL MYERS SQUIBB CO
No USPTO patent applications found for BRISTOL MYERS SQUIBB CO.
Annual Financials
From BMY's 10-K filings · XBRL
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $48.19B | $48.30B | $45.01B | $46.16B | $46.38B |
| Net income | $7.05B | -$8.95B | $8.03B | $6.33B | $6.99B |
| Diluted EPS | $3.46 | -$4.41 | $3.86 | $2.95 | $3.12 |
| Operating cash flow | $14.16B | $15.19B | $13.86B | $13.07B | $16.21B |
| Cash and equivalents | $10.21B | $10.35B | $11.46B | $9.12B | $13.98B |
| Total assets | $90.04B | $92.60B | $95.16B | $96.82B | $109.31B |
| Total liabilities | $71.53B | $76.22B | $65.67B | $65.70B | $73.31B |
| Shareholders' equity | $18.47B | $16.34B | $29.43B | $31.06B | $35.95B |
As BRISTOL MYERS SQUIBB CO tagged them in its 10-K filings: totals for the year on the income and cash-flow lines, values at the year's end on the balance-sheet lines. Latest 10-K, filed Feb 11, 2026 ↗
Stock Splits
Every split and reverse split in the price history
- 2-for-1Stock splitMar 1, 1999
- 2-for-1Stock splitMar 3, 1997
- 2-for-1Stock splitJun 10, 1987
- 2-for-1Stock splitMay 27, 1983
- 2-for-1Stock splitMay 31, 1977
Split dates and ratios from the price history · Close Prices from Tiingo.com
Material Events (8-K)
Corporate events filed with the SEC
- 8-K · Items 2.02, 7.01, 9.01Results of operations · Reg FD disclosureJul 30, 2026
EDGAR ↗ - 8-K · Items 5.07Shareholder voteMay 8, 2026
EDGAR ↗ - 8-K · Items 2.02, 7.01, 9.01Results of operations · Reg FD disclosureApr 30, 2026
EDGAR ↗ - 8-K · Items 2.02, 7.01, 9.01Results of operations · Reg FD disclosureFeb 5, 2026
EDGAR ↗ - 8-K · Items 7.01, 9.01Reg FD disclosureJan 12, 2026
EDGAR ↗ - 8-K · Items 8.01, 9.01Other eventsNov 18, 2025
EDGAR ↗ - 8-K · Items 8.01, 9.01Other eventsNov 10, 2025
EDGAR ↗ - 8-K · Items 8.01, 9.01Other eventsNov 3, 2025
EDGAR ↗ - 8-K · Items 2.02, 7.01, 9.01Results of operations · Reg FD disclosureOct 30, 2025
EDGAR ↗ - 8-K · Items 2.02, 7.01, 9.01Results of operations · Reg FD disclosureJul 31, 2025
EDGAR ↗
About BRISTOL MYERS SQUIBB CO
From SEC EDGAR company records
Industry (SIC 2834)Pharmaceutical Preparations
SectorHealthcare
HeadquartersPRINCETON, NJ
IncorporatedDE
SEC CIK0000014272 ↗